يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Cavo A."', وقت الاستعلام: 1.06s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial.

    المؤلفون: Mateos, Maria-Victoria1 (AUTHOR) mvmateos@usal.es, Cavo, Michele2 (AUTHOR), Blade, Joan3 (AUTHOR), Dimopoulos, Meletios A4 (AUTHOR), Suzuki, Kenshi5 (AUTHOR), Jakubowiak, Andrzej6 (AUTHOR), Knop, Stefan7 (AUTHOR), Doyen, Chantal8 (AUTHOR), Lucio, Paulo9 (AUTHOR), Nagy, Zsolt10 (AUTHOR), Pour, Ludek11 (AUTHOR), Cook, Mark12 (AUTHOR), Grosicki, Sebastian13 (AUTHOR), Crepaldi, Andre14 (AUTHOR), Liberati, Anna Marina15 (AUTHOR), Campbell, Philip16 (AUTHOR), Shelekhova, Tatiana17 (AUTHOR), Yoon, Sung-Soo18 (AUTHOR), Iosava, Genadi19 (AUTHOR), Fujisaki, Tomoaki20 (AUTHOR)

    المصدر: Lancet. 1/11/2020, Vol. 395 Issue 10218, p132-141. 10p.

    مصطلحات موضوعية: MULTIPLE myeloma, BOVINE viral diarrhea, RESPIRATORY infections, MONOCLONAL gammopathies, MELPHALAN, BORTEZOMIB, BODY surface area


    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Expanding CD38-targeting triplets for relapsed or refractory multiple myeloma.

    المؤلفون: Cavo, Michele1 (AUTHOR) michele.cavo@unibo.it, Tacchetti, Paola1 (AUTHOR), Zamagni, Elena1 (AUTHOR)

    المصدر: Lancet. 6/19/2021, Vol. 397 Issue 10292, p2311-2313. 3p.

    مصطلحات موضوعية: MULTIPLE myeloma


    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study.

    المؤلفون: Cavo M (AUTHOR), Tacchetti P (AUTHOR), Patriarca F (AUTHOR), Petrucci MT (AUTHOR), Pantani L (AUTHOR), Galli M (AUTHOR), Di Raimondo F (AUTHOR), Crippa C (AUTHOR), Zamagni E (AUTHOR), Palumbo A (AUTHOR), Offidani M (AUTHOR), Corradini P (AUTHOR), Narni F (AUTHOR), Spadano A (AUTHOR), Pescosta N (AUTHOR), Deliliers GL (AUTHOR), Ledda A (AUTHOR), Cellini C (AUTHOR), Caravita T (AUTHOR), Tosi P (AUTHOR)

    المصدر: Lancet. 12/18/2010, Vol. 376 Issue 9758, p2075-2085. 11p.


    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study.

    المؤلفون: Attal, Michel1 (AUTHOR) attal.michel@iuct-oncopole.fr, Richardson, Paul G1,2 (AUTHOR) paul_richardson@dfci.harvard.edu, Rajkumar, S Vincent3 (AUTHOR), San-Miguel, Jesus4 (AUTHOR), Beksac, Meral5 (AUTHOR), Spicka, Ivan6 (AUTHOR), Leleu, Xavier7 (AUTHOR), Schjesvold, Fredrik8,9 (AUTHOR), Moreau, Philippe10 (AUTHOR), Dimopoulos, Meletios A11 (AUTHOR), Huang, Jeffrey Shang-Yi12 (AUTHOR), Minarik, Jiri13 (AUTHOR), Cavo, Michele14 (AUTHOR), Prince, H Miles15 (AUTHOR), Macé, Sandrine16 (AUTHOR), Corzo, Kathryn P17 (AUTHOR), Campana, Frank17 (AUTHOR), Le-Guennec, Solenn16 (AUTHOR), Dubin, Franck16 (AUTHOR), Anderson, Kenneth C2 (AUTHOR)

    المصدر: Lancet. Dec2019, Vol. 394 Issue 10214, p2096-2107. 12p.

    مصطلحات موضوعية: *MULTIPLE myeloma, *RESPIRATORY infections, *MONOCLONAL gammopathies, *URINARY tract infections, *DEXAMETHASONE

    Reviews & Products: YOUTUBE (Web resource)


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث